-+ 0.00%
-+ 0.00%
-+ 0.00%

ProMIS Neurosciences Announces Interim Phase 1b Trial Readout for PMN310 in Alzheimer's Disease Set for Q2 2026

Reuters·12/01/2025 12:30:20

Please log in to view news